Home Tools

Prexasertib dimesylate

Catalog No. T38620 CAS 1234015-58-7

Synonyms: LY2606368 dimesylate

Prexasertib dimesylate (LY2606368 dimesylate) is a highly selective ATP-competitive second-generation inhibitor of checkpoint kinase 1 (CHK1). With a K i of 0.9 nM and an IC 50 of <1 nM, Prexasertib dimesylate effectively inhibits CHK2 (IC 50 = 8 nM) and RSK1 (IC 50 = 9 nM). Its mechanism of action involves inducing double-stranded DNA breakage and replication catastrophe, ultimately leading to apoptosis. Moreover, Prexasertib dimesylate demonstrates potent anti-tumor activity.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Prexasertib dimesylate Chemical Structure

Prexasertib dimesylate, CAS 1234015-58-7

Pack Size	Availability	Price/USD	Quantity
2 mg	5 days	$ 52.00

Bulk Inquiry

Biological Description

Chemical Properties

Storage & Solubility Information

Description	Prexasertib dimesylate (LY2606368 dimesylate) is a highly selective ATP-competitive second-generation inhibitor of checkpoint kinase 1 (CHK1). With a K i of 0.9 nM and an IC 50 of <1 nM, Prexasertib dimesylate effectively inhibits CHK2 (IC 50 = 8 nM) and RSK1 (IC 50 = 9 nM). Its mechanism of action involves inducing double-stranded DNA breakage and replication catastrophe, ultimately leading to apoptosis. Moreover, Prexasertib dimesylate demonstrates potent anti-tumor activity.
Targets&IC50	Chk1:<1 nM (IC50), Chk1:0.9 nM (Ki), Chk2:8 nM (IC50)
In vitro	Prexasertib dimesylate (LY2606368 dimesylate) demonstrates significant inhibitory activity against various kinases, including MELK (IC 50 =38 nM), SIK (IC 50 =42 nM), BRSK2 (IC 50 =48 nM), and ARK5 (IC 50 =64 nM), by targeting mechanisms crucial for cell cycle progression and mitosis. It relies on CDC25A and CDK2 to induce DNA damage. Specifically, treatment with 33 and 100 nM concentrations for 7 hours causes DNA damage during the S-phase in HeLa cells, while pretreatment at concentrations ranging from 8-250 nM for 15 minutes inhibits CHK1 (S296) and CHK2 (S516) autophosphorylation in HT-29 cells. At a lower concentration of 4 nM over 24 hours, it induces a substantial cell cycle shift from G1 and G2-M to S-phase, accompanied by an increase in H2AX phosphorylation in U-2 OS cells. A concentration of 33 nM for 12 hours leads to chromosomal fragmentation in HeLa cells, and at 100 nM from 0.5 to 9 hours, it triggers replication stress and reduces the availability of RPA2 for DNA binding. Cell cycle analysis and Western blot analyses further confirm its impact, revealing DNA damage in the G2-M population and inhibition of CHK1 and CHK2 autophosphorylation at concentrations as low as 31 nM in HeLa and HT-29 cells respectively.
In vivo	Prexasertib dimesylate (LY2606368 dimesylate), administered subcutaneously (SC) at dosages of 1-10 mg/kg twice daily for three cycles (each comprising 3 days of treatment followed by 4 days of rest), demonstrated significant inhibition of tumor growth in xenograft models[1]. At a higher dosage of 15 mg/kg, administered SC, this compound effectively inhibited CHK1 in the blood and induced phosphorylation of H2AX (S139) and RPA2 (S4/S8), indicating rapid DNA damage[1]. These studies were conducted using female CD-1 nu-/nu- mice (26-28 g) implanted with Calu-6 cells. For the tumor growth inhibition study, dosages of 1, 3.3, or 10 mg/kg resulted in up to 72.3% reduction in tumor size. In pharmacokinetic analysis at 15 mg/kg, CHK1 levels in plasma were 7 ng/mL at 12 hours, decreasing to 3 ng/mL by 24 hours, with detectable phosphorylation of H2AX and RPA2 as early as 4 hours post-administration, demonstrating the compound's swift action in causing DNA damage.

Synonyms	LY2606368 dimesylate
Molecular Weight	557.6
Formula	C20H27N7O8S2
CAS No.	1234015-58-7

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

References and Literature

1. King C, et al. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Mol Cancer Ther. 2015 Sep;14(9):2004-1 2. Yin Y, et al. Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer. Am J Cancer Res. 2017 Mar 1;7(3):473-483.

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Prexasertib dimesylate 1234015-58-7 LY2606368 Dimesylate LY2606368 dimesylate Prexasertib LY2606368 LY-2606368 Dimesylate LY-2606368 LY 2606368 Prexasertib Dimesylate LY 2606368 Dimesylate inhibitor inhibit

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.